CLAPS, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 6.014
AS - Asia 5.158
EU - Europa 3.404
SA - Sud America 786
AF - Africa 152
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.565
Nazione #
US - Stati Uniti d'America 5.734
SG - Singapore 1.785
CN - Cina 1.154
IT - Italia 1.060
BR - Brasile 547
HK - Hong Kong 518
SE - Svezia 427
VN - Vietnam 398
KR - Corea 317
FR - Francia 273
BD - Bangladesh 230
DE - Germania 229
GB - Regno Unito 210
IN - India 198
RU - Federazione Russa 182
NL - Olanda 167
CA - Canada 160
PL - Polonia 154
FI - Finlandia 112
TR - Turchia 112
JP - Giappone 91
IE - Irlanda 87
ES - Italia 85
BG - Bulgaria 84
AR - Argentina 79
MX - Messico 64
CH - Svizzera 62
CO - Colombia 58
ID - Indonesia 56
AT - Austria 52
MA - Marocco 48
BE - Belgio 41
PK - Pakistan 40
AU - Australia 39
IR - Iran 39
UA - Ucraina 35
EC - Ecuador 28
IQ - Iraq 27
PH - Filippine 27
RO - Romania 26
ZA - Sudafrica 26
CL - Cile 25
TW - Taiwan 23
SA - Arabia Saudita 22
TN - Tunisia 19
EG - Egitto 18
CZ - Repubblica Ceca 17
MY - Malesia 16
VE - Venezuela 15
PT - Portogallo 14
KE - Kenya 13
LT - Lituania 13
TH - Thailandia 13
GR - Grecia 12
JO - Giordania 12
IL - Israele 11
PY - Paraguay 11
UZ - Uzbekistan 11
JM - Giamaica 10
NP - Nepal 10
AL - Albania 9
CR - Costa Rica 9
BO - Bolivia 8
HU - Ungheria 8
PE - Perù 8
KZ - Kazakistan 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
CU - Cuba 6
DK - Danimarca 6
HR - Croazia 6
AZ - Azerbaigian 5
GE - Georgia 5
GH - Ghana 5
NO - Norvegia 5
OM - Oman 5
QA - Qatar 5
SN - Senegal 5
CI - Costa d'Avorio 4
ET - Etiopia 4
GT - Guatemala 4
KG - Kirghizistan 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
BB - Barbados 3
EU - Europa 3
HN - Honduras 3
LB - Libano 3
NI - Nicaragua 3
PA - Panama 3
RS - Serbia 3
BS - Bahamas 2
DZ - Algeria 2
EE - Estonia 2
GA - Gabon 2
KW - Kuwait 2
Totale 15.535
Città #
Singapore 1.064
Ashburn 690
San Jose 561
Hong Kong 495
Chandler 332
Seoul 297
Hefei 282
Beijing 241
Chicago 238
Trieste 211
Los Angeles 189
Fairfield 186
Boardman 144
Ho Chi Minh City 140
Ann Arbor 117
Seattle 115
Princeton 114
Wilmington 113
Santa Clara 109
Lauterbourg 107
Milan 104
Columbus 102
Zgierz 96
Houston 90
New York 90
Council Bluffs 83
Hanoi 83
Woodbridge 82
Dallas 80
Sofia 80
Dublin 79
The Dalles 76
Moscow 75
São Paulo 75
Buffalo 69
Cambridge 68
Helsinki 66
Frankfurt am Main 61
Toronto 61
London 52
Rome 50
Bern 49
Jacksonville 48
Orem 45
Salt Lake City 42
Munich 41
Warsaw 41
Shanghai 40
Elk Grove Village 37
Guangzhou 37
Tokyo 36
Redwood City 35
Atlanta 34
Casablanca 33
Lappeenranta 32
Vienna 31
Bogotá 29
Brussels 28
Tampa 28
Montreal 27
Chennai 26
Nuremberg 25
Phoenix 25
Brooklyn 24
Redmond 24
Boston 23
Istanbul 23
Washington 23
San Diego 22
Ankara 21
Palermo 21
Madrid 20
Manchester 20
Rio de Janeiro 20
Denver 19
Paris 19
Düsseldorf 18
Haiphong 18
Tehran 18
North Bergen 17
Pune 17
Redondo Beach 17
Norwalk 16
Sterling 16
Amsterdam 15
Buenos Aires 15
Johannesburg 15
Poplar 15
Da Nang 14
Dhaka 14
Jakarta 14
Mexico City 14
Stockholm 14
Bengaluru 13
Curitiba 13
Lahore 13
Lancaster 13
Naples 13
Dong Ket 12
Hamilton 12
Totale 8.771
Nome #
Gender affirming surgery: Vaginoplasty and clitoroplasty with modified peno-scrotal flap technique 701
Machine Learning and External Validation of the IDENTIFY Risk Calculator for Patients with Haematuria Referred to Secondary Care for Suspected Urinary Tract Cancer 522
MtF sex reassignment surgery: Trombetta technique 477
Warm ischemia time length during on-clamp partial nephrectomy: dose it really matter? 295
Focal testicular lesions. Multiparametric us features and association with histopathology 278
Preoperative impact of albumin to fibrinogen ratio (AFR) on oncological outcomes in patients with muscle invasive bladder cancer treated with radical cystectomy 277
Utility of serum markers in the assessment of perioperative and postoperative morbidity and mortality after radical cystectomy 263
Testis sparing surgery: Results of a large multicentric retrospective study 257
Testis Sparing Surgery of Small Testicular Masses: Retrospective Analysis of a Multicenter Cohort 252
Analysis of clinical utility of abdominopelvic computer tomography in the follow up of Stage I Seminoma. A single center evaluation 240
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients 222
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy 219
Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy 215
Analysis of clinical utility of abdominopelvic computer tomography in the surveillance of stage I seminoma. A single center evaluation 203
The role of preoperative controlling nutrtional status (CONUT) score in the assessment of pathological features and survival outcomes in clear-cell renal cell carcinoma (ccRCC): A population-based study 201
Learning Curve for Endoscopic Combined Intra-Renal Surgery Using Vacuum-Assisted Device 200
Predictors of residual tumor at re-staging transurethral resection for high-risk non-muscle invasive bladder cancer 188
Reliable Prediction of Post-Operative Complications’ Rate Using the G8 Screening Tool: A Prospective Study on Elderly Patients Undergoing Surgery for Kidney Cancer 179
P-04-10 Italian Residents in Urology Sexual Health: A Multicentric Study 179
Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry 178
An Observational Cohort Study Investigating the Incidence Rate of Infectious Complications After Routine Office Nephrostomy Tube Replacement Without Using Antimicrobial Prophylaxis 178
Impact of preoperative Controlling nutritional status (CONUT) score on perioperative morbidity and survival outcomes in patients with bladder cancer treated with radical cystectomy 177
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular Targets 173
PD60-10 IMPACT OF PREOPERATIVE CONTROLLING NUTRITIONAL STATUS (CONUT) SCORE ON PERIOPERATIVE MORBIDITY AND SURVIVAL OUTCOMES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADICAL CYSTECTOMY: A MULTICENTER ANALYSIS 172
Improving pre-operative planning of robot assisted nephron sparing surgery using three-dimensional anatomical model 170
MP80-05 TREND, CHARACTERISTICS AND IMPACT ON CANCER-SPECIFIC MORTALITY OF INCIDENTAL RENAL MASSES: RESULTS FROM A LARGE SERIES OF AUTOPSIES 169
Impact of the COVID-19 pandemic on urology residency training in Italy 162
Infective complications after nephrostomy tube replacement without use of antimicrobical prophylaxis: A prospective study 160
Assessing Trifecta Achievement after Percutaneous Cryoablation of Small Renal Masses: Results from a Multi-Institutional Collaboration 153
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study 152
Free-indocyanine green-guided pelvic lymph node dissection during radical prostatectomy 151
Procalcitonin as prognostic factor in patients with Fournier's gangrene 151
Analysis of Bacterial Stent Colonization: The Role of Urine and Device Microbiological Cultures 151
The role of preoperative cart score as predictor of renal functional decline after partial nephrectomy 151
Developing a Diagnostic Multivariable Prediction Model for Urinary Tract Cancer in Patients Referred with Haematuria: Results from the IDENTIFY Collaborative Study 150
Rebiopsy rate after transperineal or transrectal prostate biopsy 149
The Utility of Inflammatory Serum Markers in the Assessment of Perioperative Morbidity after Radical Cystectomy for Bladder Cancer 148
Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility 148
External validation of yonsei nomogram predicting chronic kidney disease development after partial nephrectomy: An international, multicenter study 148
Optimization of the different therapeutic strategies in muscle invasive bladder cancer using biomarkers 147
Time for a change in the management of small testicular masses: Results of a large multicentric retrospective study on testis sparing surgery 146
The role of preoperative controlling nutritional status (CONUT) score in the assessment of survival outcomes in patients with muscle invasive bladder cancer (MIBC) treated with radical cystectomy: A pilot study 146
Validation of the Italian version of wisconsin stone quality of life (WISQOL): a prospective Italian multicenter study 145
Artificial Intelligence in Bladder Cancer Diagnosis: Current Applications and Future Perspectives 145
Risk factors of bladder cancer in patients undergoing transurethral cystoscopy: A multicentric italian experience from the IDENTIFY study cohort 143
A survey on preferences, attitudes, and perspectives of Italian urology trainees: implications of the novel national residency matching program 142
Prognostic value of preoperative albumin-to-fibrinogen ratio (AFR) in patients with bladder cancer treated with radical cystectomy 142
Reliability of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: A precision study 141
Double-Layered Hand-Sewn versus Stapled Intestinal Anastomosis in Patients Who Underwent Ileal Urinary Diversion in Radical Cystectomy: A Comparative and Cost Effective Study 140
Management of stuttering priapism 140
Preliminary results from an independent analysis of the italian cohort of the identify study: Baseline features of italian patients investigated for suspicious urinary tract malignancy at 5 italian tertiary referral centers 139
Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Biopsy 139
Impact of antiplatlet or anticoagulation therapy in patients newly diagnosed bladder cancer: Preliminary results of a independent analysis of the Identify Study Italian cohort 138
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis 135
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma 135
Antibiotic prophylaxis in patients who had undergone to prostate biopsy in between the EMA warning era: effects of fluoroquinolones in diabetic and non-diabetic patients. Results of an observational cohort study 135
Plication surgery does not produce additional loss of length in Peyronie’s disease patients 133
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature 132
Evaluation of Fluorescent Confocal Microscopy for Intraoperative Analysis of Prostate Biopsy Cores 132
Incidence, predictive factors and survival outcomes of incidental prostate cancer in patients who underwent radical cystectomy for bladder cancer 130
MP14-07 PERFORMANCE OF A NEW RISK ASSESSMENT TOOL FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA UNDERGOING CYTOREDUCTIVE NEPHRECTOMY IN THE TARGETED THERAPY ERA: REMARCC SCORE 129
Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC) 129
Intraoperative laparoscopic ICG-guidance extended pelvic lymph node dissection in patients with intermediate and high-risk prostate cancer who underwent radical prostatectomy: A matched case-control study 127
COVID-19 outbreak impact on urolithiasis treatments: A multicenter retrospective study across 9 urological centers 124
Fluorescence Confocal Microscopy in Urological Malignancies: Current Applications and Future Perspectives 121
Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors 116
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival 115
Frequency of testicular torsion presenting with abdominal pain in adults: a retrospective analysis of diagnostic and management implications 114
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum 114
Focus on the Use of Resveratrol in Bladder Cancer 110
External validation of nephrolithometric nomograms in patients treated with minimally invasive percutaneous nephrolithotomy: a multicentric prospective study 110
Targeted Prostate Biopsy: How, When, and Why? A Systematic Review 109
MP46-17 INFECTIVE COMPLICATIONS AFTER NEPHROSTOMY TUBE REPLACEMENT WITHOUT USE OF ANTIMICROBICAL PROPHYLAXIS: A PROSPECTIVE STUDY 109
Novel Expanding Renal Cell Carcinoma Biomarkers 109
Idiopathic Retroperitoneal Fibrosis: What Is the Optimal Clinical Approach for Long-Term Preservation of Renal Function? 108
Arterioureteral fistula: An unusual cause of haematuria 10 years after the implantation of a synthetic iliac-femoral stent 107
The Added Value of Controlling Nutritional Status (Conut) Score for Preoperative Counselling on Significant Early Loss of Renal Function After Radical Nephrectomy for Renal Cell Carcinoma 104
Smart learning for urology residents during the COVID-19 pandemic and beyond: insights from a nationwide survey in Italy 102
The IDENTIFY Study: The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer; A multicentre observational study 102
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis? 101
The impact of sarcomatoid features on survival outcomes in metastatic renal cell carcinoma patients receiving upfront cytoreductive nephrectomy: a retrospective analysis of a contemporary series 100
Editorial Comment [to "Financial Toxicity After Robot-Assisted Radical Prostatectomy and Its Relation with Oncologic, Functional Outcomes"] 99
Exploring the Residents’ Perspective on Smart learning Modalities and Contents for Virtual Urology Education: Lesson Learned During the COVID-19 Pandemic 98
Prostate cancer patients with lymphatic node involvement detected by immunohistochemistry. Is the effort worthwhile? 96
Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective study 95
Reply by Authors 93
Promising Biomarkers in Renal Cell Carcinoma 92
MP25-12 PREDICTORS OF MAJOR COMPLICATIONS AFTER CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: INSIGHTS FROM A RETROSPECTIVE MULTICENTRE REGISTRY 90
Slowdown of urology residents’ learning curve during the COVID-19 emergency 89
Laroscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of Indocyanine Green: Results from a prospective study 86
Laparoscopic radical prostatectomy using a real-time lymphangiography with transperineal injection of indocyanine green: Results from a prospective study 86
Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach 85
Applications of Platelet Concentrates (PCs) in Regenerative Onco-Urology: A Systematic Review of Literature 83
Enhanced prognostic value of four‐tier hybrid grading system in Ta non‐muscle‐invasive bladder cancer 81
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical Cystectomy 80
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy 80
The significance of isolated de novo red patches in the bladder in patients referred with suspected urinary tract cancer: Results from the IDENTIFY study 80
Molecular markers of systemic therapy response in urothelial carcinoma 74
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleeding 73
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC) 69
Totale 15.473
Categoria #
all - tutte 51.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.537


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202183 0 0 0 0 0 0 0 0 0 0 0 83
2021/2022845 34 67 75 110 25 26 37 55 121 99 31 165
2022/20231.393 127 205 76 180 62 204 51 127 178 55 77 51
2023/20241.483 103 75 79 81 121 138 289 224 42 56 151 124
2024/20253.356 102 257 364 317 270 269 212 158 447 370 264 326
2025/20267.661 966 412 600 685 525 607 877 289 654 913 514 619
Totale 16.000